Yi Zhang

92PUBLICATIONS
132CO-AUTHORS
Molecular targetsPredictive and prognostic markersInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (92)

|Aug 11, 2026
H2AFY2 suppresses exhaustion and enhances antitumor activity of CAR-T cells through transcriptional and epigenetic modifications.

|May 22, 2026
Macrophage-derived fibronectin suppresses antitumor immunity via tissue stiffening and immunosuppressive cell induction in cancer mouse models.

|May 19, 2026
Targeting cysteinyl leukotriene receptor 1 reprograms tumor-promoting myelopoiesis and overcomes immune checkpoint therapy resistance.

|May 01, 2026
Citraconate preserves T cell stemness and antitumor immunity.

|Mar 10, 2026
Efficacy and immunomodulatory effect of Claudin18.2-specific IL-7/XCL1 armored CAR-T cells in digestive tract cancer: preclinical and clinical analysis.

Xuan Zhao, Jinyan Liu, Zhen Zhang

|Oct 20, 2025
TREM2-Mediated Cholesterol Efflux in Macrophages Inhibits Anti-Tumor Immunity via Limitation of CD4+ T and NK Cells.

Yunhan Wang, Weina Yu, Xinxin Wang

Pageof 16

Frequent Collaborators

8 joint publications

Bin Zhang

7 joint publications

Feng Li

6 joint publications

Bo Huang

5 joint publications

Qitai Zhao